2022-2023 EVENTS

2022 Events

28 Aug - 01 Sep 2022
The International Surgical Week (ISW)
Kuala Lumpur

31 Aug – 2 Sept 2022
Medical Fair Asia
Marina Bay Sands, Singapore

3-9 September
Medical Fair Asia
Digital, Online

9-10 September 2022
World Pediatrics Conference
Bangkok, Thailand

9-10 September 2022
World Heart and Cardiothoracic Surgery Conference
Bangkok, Thailand

19-21 September 2022
23rd SE-Asian Healthcare & Pharma Show
Kuala Lumpur

27-29 September 2022
Smart Healthcare Expo (Health Malaysia)

27-29 September 2022
Asia Pandemic Congress
Kuala Lumpur Convention Centre

19-20 September 2022
23nd Global Nursing Education Conference
Brisbane, Australia

30 Sep - 2 Oct 2022
Malaysia International Dental Show (MIDS)
Sunway Pyramid Convention Centre, Subang Jaya, Malaysia

7-9 November 2022
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center

7-9 November 2022
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center

11-13 November 2022
Eldercare Exhibition and Conference Asia (ELDEX Asia 2022)
Suntex Singapore Exhibition and Convention Centre

14-15 November 2022
Healthcare Asia Pacific
Osaka, Japan

2023 Events

30 May – 1 June 2023
KL Convention Centre, Kuala Lumpur

13-15 September 2023
Medical Fair Thailand
BITEC, Bangkok

Free counters!

Health DG

The Ministry of Health (MOH) has agreed to the listing of all polymyxins as prohibited substances in all veterinary medicines for all target species, except for veterinary medicines containing Polymyxin B in topical preparation forms.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the decision was made at the 381st Drug Control Authority (DCA) Meeting on Feb 2 as a step to reduce the risk of antimicrobial resistance (AMR) to polymyxins.

“Polymyxin, especially Polymyxin E (Colistin) has the potential to be misused in animal feed as a growth promoter agent. The widespread use of Polymyxin E (Colistin) can contribute to AMR,” he said in a statement here today.

As such, he said the meeting also agreed that the cancellation of registration of registered veterinary medicines containing Polymyxin E (Colistin) would take effect immediately.

Dr Noor Hisham said the manufacturing, importing and supplying of the product are also prohibited with immediate effect, while Product Registration holders are allowed to use up existing stock in the market within three months from the date of the product cancellation letter.

“The DCA Meeting also agreed with the decision not to consider re-registration applications for veterinary medicines containing polymyxins (except polymyxin B in the form of topical preparations) with immediate effect,” he said.

Polymyxins (such as Polymyxin E (Colistin) and Polymyxin B) have been categorised as Critically Important Antimicrobials by the World Health Organization (WHO) based on Annex 1 of the WHO Critically Important Antimicrobials for Human Medicine publication.

Polymyxins have also been categorised as the highest priority based on Table 2: Prioritization of antimicrobials categorized as “Critically Important” in human medicine because they have met all the prioritisation factors, Dr Noor Hisham added. – Bernama